Market Research Logo

Global Anaplastic Thyroid Cancer Drugs Market 2019-2023

Global Anaplastic Thyroid Cancer Drugs Market 2019-2023

Global Anaplastic Thyroid Cancer Drugs Market: About this market

Technavio’s anaplastic thyroid cancer drugs market analysis considers sales from both chemotherapy and novel therapy. Our report also finds the sales of anaplastic thyroid cancer drugs in North America, Europe, Asia, and ROW. In 2018, chemotherapy segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high prevalence of thyroid cancer will play a significant role in the chemotherapy segment to maintain its market position. Also, our global anaplastic thyroid cancer drugs market report looks at factors such as the introduction of targeted therapies, and the rising geriatric population and high prevalence of thyroid cancer. However, the adverse effects of chemotherapy, availability of substitutes, and stringent regulations may hamper the growth of the anaplastic thyroid cancer drugs industry over the forecast period.

Global anaplastic thyroid cancer drugs market: Overview

Introduction of targeted therapies

The adverse effects associated with the off-label medicines available in the market has led to the development of targeted therapies for cancer treatments. The mutations of the BRAF gene cause most of the cases of anaplastic thyroid cancer. Hence, BRAF kinase inhibitors are one of the most foreseen small molecule targeted therapy drugs for the treatment of anaplastic thyroid cancer. Thus, the introduction of targeted therapies will lead to the expansion of the anaplastic thyroid cancer drugs market at a CAGR of more than 4% during the forecast period.

Reimbursement policies for chemotherapy

The high cost of off-label therapies such as chemotherapy remains a challenge for patients and the healthcare system. To overcome this challenge, governments and NGOs are focusing on providing financial assistance for the treatment of various cancer indications, including anaplastic thyroid cancer. This encourages many patients to avail off-label treatments, which will lead to an increase in the patient base. Thus, the increasing availability of reimbursement policies for chemotherapy will fuel market growth during the forecast period.

For the detailed list of factors that will drive the global anaplastic thyroid cancer drugs market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global anaplastic thyroid cancer drugs market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs manufacturers, that include Bristol-Myers Squibb Co., Celgene Corp., Eisai Co. Ltd., Johnson & Johnson Services Inc., and Novartis AG.

Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global oncology therapeutics market
      • Table Segments of global oncology therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Chemotherapy - Market size and forecast 2018-2023
      • Table Chemotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Chemotherapy - Year-over-year growth 2019-2023 (%)
    • Novel therapy - Market size and forecast 2018-2023
      • Table Novel therapy - Market size and forecast 2018-2023 ($ millions)
      • Table Novel therapy - Year-over-year growth 2019-2023 (%)
      • Table Patient assistance programs
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Global growth in geriatric population in the last five years (%)
    • Market challenges
      • Table Adverse effects associated with available drugs for treatment of anaplastic thyroid cancer
      • Table Impact of drivers and challenges
  • Market trends
    • Table Drug development pipeline: Late-stage molecules for anaplastic thyroid cancer
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. - Vendor overview
      • Table Bristol-Myers Squibb Co. - Product segments
      • Table Bristol-Myers Squibb Co. - Organizational developments
      • Table Bristol-Myers Squibb Co. - Geographic focus
      • Table Bristol-Myers Squibb Co. - Key offerings
      • Table Bristol-Myers Squibb Co. - Key customers
    • Celgene Corp.
      • Table Celgene Corp. - Vendor overview
      • Table Celgene Corp. - Business segments
      • Table Celgene Corp. - Organizational developments
      • Table Celgene Corp. - Geographic focus
      • Table Celgene Corp. - Key offerings
      • Table Celgene Corp. - Key customers
    • Eisai Co. Ltd.
      • Table Eisai Co. Ltd. - Vendor overview
      • Table Eisai Co. Ltd. - Business segments
      • Table Eisai Co. Ltd. - Organizational developments
      • Table Eisai Co. Ltd. - Geographic focus
      • Table Eisai Co. Ltd. - Segment focus
      • Table Eisai Co. Ltd. - Key offerings
      • Table Eisai Co. Ltd. - Key customers
    • Johnson & Johnson Services Inc.
      • Table Johnson & Johnson Services Inc. - Vendor overview
      • Table Johnson & Johnson Services Inc. - Business segments
      • Table Johnson & Johnson Services Inc. - Organizational developments
      • Table Johnson & Johnson Services Inc. - Geographic focus
      • Table Johnson & Johnson Services Inc. - Segment focus
      • Table Johnson & Johnson Services Inc. - Key offerings
      • Table Johnson & Johnson Services Inc. - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report